REGEN BIOPHARMA, INC. (RGBP) Operating cash flow 2017–2025
REGEN BIOPHARMA, INC. (RGBP) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$383,591FY2025 · since FY2017: -$1.9M → -$383,591
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$383,591 | +49.0% |
| FY2024 | -$751,536 | -332.1% |
| FY2023 | -$173,917 | +71.3% |
| FY2022 | -$606,921 | +46.3% |
| FY2021 | -$1.1M | -6165.6% |
| FY2020 | $18,645 | +103.9% |
| FY2019 | -$481,792 | +69.5% |
| FY2018 | -$1.6M | +16.7% |
| FY2017 | -$1.9M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More RGBP financial trends
RGBP RevenueRGBP Net incomeRGBP Net marginRGBP Gross profitRGBP Gross marginRGBP Operating incomeRGBP Operating marginRGBP Free cash flowRGBP Capital expendituresRGBP Return on equityRGBP Stock buybacksRGBP Dividends paidRGBP Total assetsRGBP Total liabilitiesRGBP Shareholders’ equityRGBP overview →